People Biography

Maha Al-Thani is a Research Fellow at Qatar Biomedical Research Center. Her primary research focus is human iPSC disease modeling and neurovascular unit co-culture. She received her PhD in Clinical Neurosciences from the University of Cambridge, and her dissertation “hiPSC-Derived Cerebral Small Vessel Disease Models”, published in 2023, was centered around blood-brain barrier modeling that led to novel hiPSC-derived models of the cerebral Small Vessel Disease variants COL4A1/2 and HTRA1. These models were later used in a drug-screening collaboration with AstraZeneca. The project was funded by the British Heart Foundation, Alzheimer’s Association, Stroke Association and Medical Research Foundation.